Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults

Status:
Recruiting

Trial end date:
2022-06-17

Target enrollment:

Participant gender:

The objective of our study is to evaluate safety, tolerability, and immunogenicity of COVID-19 preventive DNA vaccine in healthy volunteers.

Phase 1/Phase 2

Genexine, Inc.

Vaccines